Literature DB >> 32004910

Identification of canine IgG and its subclasses, IgG1, IgG2, IgG3 and IgG4, by immunofixation and commercially available antisera.

Dillon Donaghy1, A Russell Moore2.   

Abstract

Immunofixation is a diagnostic and research tool used for characterizing the electrophoretic location of immunoglobulin fractions in serum and urine. Commercially available polyclonal antisera which discriminate two IgG subclasses (IgG1 and IgG2) are available and commonly used. More recently, four IgG subclasses have been defined in the dog based on cDNA data. Archived serum from 16 dogs with naturally occurring monoclonal or biclonal gammopathies were characterized using routine serum protein electrophoresis, routine immunofixation and LCMS/MS as 3 IgA, 3 IgM, 2 IgG2, 7 IgG3 and 2 IgG4 heavy chain predominant cases. Immunofixation reactivity of a panel of commercially available antisera to these cases was characterized. The anti-human IgG antisera was the only tested antisera which bound all canine IgG restricted bands without also labelling IgA or IgM heavy chains or light chains. The tested polyclonal antisera labeled as reacting with canine IgG2 bound canine IgG2, IgG3, IgA and IgM and may label IgG1. The tested polyclonal antisera labeled as reacting with canine IgG1 bound the canine IgG4 bands but not those identified as IgA, IgM, IgG2 or IgG3 and likely did not bind IgG1. This data suggests that commercially available polyclonal IgG1 antisera (Bethyl A40 - 120A and Bio-Rad AHP947) can be used to positively but possibly not selectively identify canine IgG4 by immunofixation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dog; IgG-D; IgG4 related disease; Monoclonal gammopathy

Mesh:

Substances:

Year:  2020        PMID: 32004910     DOI: 10.1016/j.vetimm.2020.110014

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Progressive gammopathy and coagulopathy in a young English bulldog.

Authors:  Jennifer L Grady; Anne Avery; A Russell Moore; Lauren J Harris; Neketa Kakar; Emily D Rout
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine.

Authors:  Verena Te Kamp; Virginia Friedrichs; Conrad M Freuling; Ad Vos; Madlin Potratz; Antonia Klein; Luca M Zaeck; Elisa Eggerbauer; Peter Schuster; Christian Kaiser; Steffen Ortmann; Antje Kretzschmar; Katharina Bobe; Michael R Knittler; Anca Dorhoi; Stefan Finke; Thomas Müller
Journal:  Vaccines (Basel)       Date:  2021-01-14

3.  Light chain myeloma and detection of free light chains in serum and urine of dogs and cats.

Authors:  Robert Adam Harris; Matthew Miller; Dillon Donaghy; Laura Ashton; Catherine Langston; Todd Shockey; A Russell Moore
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

4.  Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells.

Authors:  Robert Hullsiek; Yunfang Li; Kristin M Snyder; Sam Wang; Da Di; Antonella Borgatti; Chae Lee; Peter F Moore; Cong Zhu; Chiara Fattori; Jaime F Modiano; Jianming Wu; Bruce Walcheck
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

5.  Polyclonal B-cell lymphocytosis in English bulldogs.

Authors:  Emily D Rout; A Russell Moore; Robert C Burnett; Julia D Labadie; Kelly L Hughes; Paul A Navin; Janna A Yoshimoto; Paul R Avery; Anne C Avery
Journal:  J Vet Intern Med       Date:  2020-10-15       Impact factor: 3.333

6.  Retrospective evaluation of the use of the International Myeloma Working Group response criteria in dogs with secretory multiple myeloma.

Authors:  A Russell Moore; Adam Harris; Christina Jeffries; Paul R Avery; Kate Vickery
Journal:  J Vet Intern Med       Date:  2020-11-20       Impact factor: 3.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.